Covered recipient · General Payments record
AYESHA A ALI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021
$36,948.75
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $36,948.75 | 19 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $36,948.75 | 19 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $36,948.75 | 19 |
Payment records · PY2021 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $2,004.00 | 08/24/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850017 | CMS |
| AbbVie Inc. | $2,004.00 | 08/30/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850021 | CMS |
| AbbVie Inc. | $2,004.00 | 09/07/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850025 | CMS |
| AbbVie Inc. | $1,603.20 | 09/13/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850029 | CMS |
| AbbVie Inc. | $2,004.00 | 09/20/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850033 | CMS |
| AbbVie Inc. | $2,004.00 | 09/28/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850037 | CMS |
| AbbVie Inc. | $2,004.00 | 10/04/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850041 | CMS |
| AbbVie Inc. | $2,004.00 | 10/11/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850045 | CMS |
| AbbVie Inc. | $2,004.00 | 10/18/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850049 | CMS |
| AbbVie Inc. | $2,004.00 | 10/25/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850053 | CMS |
| AbbVie Inc. | $2,004.00 | 11/07/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850057 | CMS |
| AbbVie Inc. | $2,004.00 | 11/08/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850061 | CMS |
| AbbVie Inc. | $2,004.00 | 11/15/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850065 | CMS |
| AbbVie Inc. | $2,004.00 | 11/22/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850069 | CMS |
| AbbVie Inc. | $1,678.35 | 11/30/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850073 | CMS |
| AbbVie Inc. | $2,004.00 | 12/06/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850077 | CMS |
| AbbVie Inc. | $2,004.00 | 12/14/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850081 | CMS |
| AbbVie Inc. | $2,004.00 | 12/21/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850085 | CMS |
| AbbVie Inc. | $1,603.20 | 12/30/2021 | Consulting Fee | Undisputed | 01/23/2026 | 793850089 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.